Guinea vs Peru: HIV/AIDS deaths averted by antiretroviral therapy
Guinea
6,473 deaths
in 2024
Peru
6,549 deaths
in 2024
Guinea rank
31st
Peru rank
30th
HIV/AIDS deaths averted by antiretroviral therapy over time
- Guinea
- Peru
How they compare
Peru currently reports 6,549 deaths against 6,473 deaths in Guinea, a difference of 76 deaths.
The two have swapped places 4 times across 35 shared years of data; in 1990 it was Peru ahead.
Guinea ranks 31st and Peru ranks 30th of 157 countries.
Peru has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Guinea | Peru | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 0 deaths | 0 deaths | — |
| 2000s | 690.29 deaths | 908.88 deaths | 218.59 deaths | Peru |
| 2010s | 3,770 deaths | 4,028 deaths | 258.72 deaths | Peru |
| 2020s | 5,733 deaths | 6,039 deaths | 305.36 deaths | Peru |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Guinea or Peru?
- Peru, at 6,549 deaths against 6,473 deaths in Guinea as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Guinea and Peru?
- 76 deaths, with Peru ahead.
- How many years of comparable data are there for Guinea and Peru?
- 35 years are reported by both, from 1990 to 2024.
- How do Guinea and Peru rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Guinea ranks 31st and Peru ranks 30th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.